Aurobindo Pharma Limited
Bandhan Mutual Fund no longer appears on the shareholder list for Aurobindo Pharma Limited, indicating the fund has either completely exited or reduced its stake below the 1 percent disclosure threshold.
A major manufacturer of active pharmaceutical ingredients and generic pharmaceuticals, Aurobindo Pharma produces a diverse range of pharmaceutical products serving domestic and international markets. The company operates across multiple therapeutic segments and maintains manufacturing facilities that comply with global quality standards. Its vertically integrated operations, coupled with significant research and development capabilities, distinguish it as a key player in India's pharmaceutical sector.
Formerly IDFC Mutual Fund, rebranded after Bandhan Financial Holdings acquired IDFC's AMC in 2023. Manages over Rs 1.5 lakh crore. Known for strong debt and liquid funds, plus well-regarded equity offerings including the IDFC-lineage Sterling Value Fund and Focused Equity Fund. One of the cleaner transitions in Indian AMC ownership history.